Christopher David Ozeroff - Net Worth and Insider Trading
Christopher David Ozeroff Net Worth
The estimated net worth of Christopher David Ozeroff is at least $108,299 dollars as of 2024-12-28. Christopher David Ozeroff is the S.V.P., General Counsel of ARCA biopharma Inc and owns about 4,247 shares of ARCA biopharma Inc (ABIO) stock worth over $108,299. Details can be seen in Christopher David Ozeroff's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Christopher David Ozeroff has not made any transactions after 2021-11-22 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Christopher David Ozeroff
Christopher David Ozeroff Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Christopher David Ozeroff owns 1 companies in total, including ARCA biopharma Inc (ABIO) .
Click here to see the complete history of Christopher David Ozeroff’s form 4 insider trades.
Insider Ownership Summary of Christopher David Ozeroff
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
ABIO | ARCA biopharma Inc | 2021-11-22 | S.V.P. & General Counsel |
Christopher David Ozeroff Latest Holdings Summary
Christopher David Ozeroff currently owns a total of 1 stock. Christopher David Ozeroff owns 4,247 shares of ARCA biopharma Inc (ABIO) as of November 22, 2021, with a value of $108,299.
Latest Holdings of Christopher David Ozeroff
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
ABIO | ARCA biopharma Inc | 2021-11-22 | 4,247 | 25.50 | 108,299 |
Holding Weightings of Christopher David Ozeroff
Christopher David Ozeroff Form 4 Trading Tracker
According to the SEC Form 4 filings, Christopher David Ozeroff has made a total of 1 transactions in ARCA biopharma Inc (ABIO) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in ARCA biopharma Inc is the acquisition of 4,167 shares on November 22, 2021, which cost Christopher David Ozeroff around $113,000.
Insider Trading History of Christopher David Ozeroff
- 1
Christopher David Ozeroff Trading Performance
GuruFocus tracks the stock performance after each of Christopher David Ozeroff's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Christopher David Ozeroff is -11.66%. GuruFocus also compares Christopher David Ozeroff's trading performance to market benchmark return within the same time period. The performance of stocks bought by Christopher David Ozeroff within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Christopher David Ozeroff's insider trading performs compared to the benchmark.
Performance of Christopher David Ozeroff
Christopher David Ozeroff Ownership Network
Christopher David Ozeroff Owned Company Details
What does ARCA biopharma Inc do?
Who are the key executives at ARCA biopharma Inc?
Christopher David Ozeroff is the S.V.P. & General Counsel of ARCA biopharma Inc. Other key executives at ARCA biopharma Inc include 10 percent owner & other: See Footnote 1 Funicular Funds, Lp , other: See Footnote 1 Funicular Fund, Lp , and other: See Remarks Jacob Ma-weaver .
ARCA biopharma Inc (ABIO) Insider Trades Summary
Over the past 18 months, Christopher David Ozeroff made no insider transaction in ARCA biopharma Inc (ABIO). Other recent insider transactions involving ARCA biopharma Inc (ABIO) include a net purchase of 634,678 shares made by ,
In summary, during the past 3 months, insiders sold 0 shares of ARCA biopharma Inc (ABIO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of ARCA biopharma Inc (ABIO) were sold and 52,890 shares were bought by its insiders, resulting in a net purchase of 52,890 shares.
ARCA biopharma Inc (ABIO)'s detailed insider trading history can be found in Insider Trading Tracker table.
ARCA biopharma Inc Insider Transactions
Christopher David Ozeroff Mailing Address
Above is the net worth, insider trading, and ownership report for Christopher David Ozeroff. You might contact Christopher David Ozeroff via mailing address: 8001 Arista Place, Suite 200, Broomfield Co 80021.